Iliac Artery Stents Market
Iliac Artery Stents Market Based on product type (Self and Balloon Expandable Stents)- Global Review 2017 to 2025
Analysis of Iliac Artery Stents market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
An iliac artery stent is small wire mesh which is used to treat the patient suffering from cardiovascular disorder. Iliac artery stent has its crucial application in holding open the iliac artery for the patent suffering from arteriosclerosis. Generally, iliac arteries are of two types, internal and external iliac arteries. The major role of the iliac artery is to carry blood from the heart to pelvis and legs. Atherosclerosis is a severe disease which affects the blood vessels such as iliac artery.
Atherosclerosis is generally caused due to deposition of fat and cholesterol within the blood vessel which lead to thickening of blood vessel wall. The thickened blood vessel wall become narrow which is responsible for the blockage of blood flow from the iliac artery. To remove this blockage from the iliac artery, a thin guide wire is inserted in the upper thigh of the patient through the small incision. This guide wire is attached with iliac artery stents and this process is generally visualized using the x-ray and special dye.
This guide wire is inserted into the femoral artery and it is guided until it reaches the iliac artery. A balloon catheter is placed on the tip of the guide wire and it is inflated inside the narrow artery. After deflation of balloon, guide wire is removed from the artery. As the balloon is deflated but the stent remains in the narrow place to remove the blockage of the blood vessel.
The rise in incidences of cardiovascular disease throughout the globe is the primary factor driving the growth of iliac artery stents market. Rapid technological advancement and wide acceptance of stenting procedure among the patent also fuelling the growth of iliac artery stents market over the forecast period. Moreover, increasing demand for minimally invasive surgery and rising geriatric population is also responsible for the robust growth of iliac artery stents market.
On other hand, various alternative treatment options are available in the market for the treatment of cardiovascular disease which will deter the growth of iliac artery stents market to some extent. Also, the number of product recall and risk of failure during the surgery will lead to the sluggish growth of this market. Additionally, stringent regulation by FDA for the approval of any stents will also hamper the growth of iliac artery stents market over the forecast period.
Iliac Artery Stents Market: Key Players
Some of the key players found across the value chain of iliac artery stents market are Boston Scientific Corporation, Cordis Corporation, Abbott Vascular, Inc, W.L. Gore & Associates, Becton, Dickinson and Company, Medtronic plc, Cook Medical Inc. and others.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Historical Actual Market Size, 2012 - 2016
- Market Size & Forecast 2017 to 2025
- Supply & Demand Value Chain
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
- Market Drivers and Restraints
Regional analysis for Market includes
- North America
- Latin America
- Asia Pacific excluding China
- The Middle East and Africa
Don't Need a Global Report?
save 40%! on Country & Region specific reports
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size
- Recent industry trends
- Key Competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
The global iliac artery stents market is classified on the basis of product type, wound type, end user and region:
Based on product type, iliac artery stents market is segmented into following:
- Balloon Expandable Stent
- Self-Expandable Stents
Based on end user, iliac artery stents market is segmented into following:
- Ambulatory Surgical Centers
- Cardiac Catheterization Centers
The global iliac artery stents market is expected to show significant growth over the forecast period owing to increased aging population and rising adoption of minimally invasive surgery. According to WHO, more than 200 million people are suffering from pulmonary artery disorder throughout the globe. WHO, also estimated that 12-20% of the global geriatric population is suffering from pulmonary artery disorder.\
By product type, balloon expandable stent will dominate the iliac artery stent market share by revenue owing to the high preference of surgeon to use this type of stent during the minimally invasive surgery. Among all end user, cardiac catheterization center will grow with the faster CAGR due to increasing number of minimally invasive surgery in this end user facility in last decade.
On the basis of geography, iliac artery stents market is classified in seven key region viz. North America, Latin America, Europe, Asia-Pacific excluding China, China, Middle East and Africa. North America is expected to dominate the global iliac Artery Stents market due high prevalence of cardiovascular disorders. After North America Iliac Artery Stents market is followed by Europe and APEC. The increasing adoption of minimally invasive surgery is responsible for robust growth iliac artery stents market in the European region.
APEC region will also show noteworthy growth for iliac artery stents market owing to rising prevalence of geriatric population in India and Japan. MEA and Latin America is expected to be a less lucrative market for iliac artery stents due lack of awareness among the patient about the minimally invasive surgery.
- FAQs -
The rise in incidences of cardiovascular disease throughout the globe is the primary factor driving the growth of iliac artery stents market.
Boston Scientific Corporation, Cordis Corporation, Abbott Vascular, Inc, W.L. Gore & Associates, Becton, Dickinson and Company, Medtronic plc, Cook Medical Inc. and others.